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Protein-bound polyamines were isolated from the plasma of mice using antipolyamine antibodies covalently 
linked to magnetic latex spheres. Their subsequent separation by polyacrylamide gel electrophoresis 
(PAGE) showed that in plasma from normal mice, 3 proteins (27, 55 and 82 kDa) carrying polyamines could 
be visualized, whereas in mice bearing the Lewis lung carcinoma at least 8 other proteins of higher molecular 
mass (5 of 94,110,130,145 and 160 kDa, and 3 of > 170 kDa) had bound polyamines. These protein-bound 
polyamines could be detected from the first week after tumour graft; they increased during the second and 
third week but decreased thereafter. These proteins were not bound by immunolatex spheres preincubated 
with spermine bound to a protein-carrier insulin. Moreover, the appearance of these protein-bound poly- 
amines was not a consequence of the inflammatory process since in mice infected with heat-inactivated Bru- 
cella abortus, with the exception of a 65 kDa protein, polyamines were bound to the same proteins found 
in normal mice. In mice grafted with the Lewis lung carcinoma the concomitant decrease in transglutamin- 
ase-mediated polyamine (e.g. putrescine) binding capacity of plasma proteins provides additional evidence 
for the presence in vivo of polyamines already bound to plasma proteins. 
Protein-bound polyamine; Cancer; Transglutaminase 
1. INTRODUCTION 
Since the first report in 1967 of antibodies to 
polyamines prepared by injecting laboratory ani- 
mals with the hapten spermine chemically coupled 
to lysozyme or bovine serum albumin [ 11, the pro- 
duction of antispermine antibodies has been 
reported by many others [2,3]. These antisera 
formed precipitates with certain human sera and 
this led to the identification of the antigen respon- 
sible for the precipitation as an az-lipoprotein with 
bound spermine. This lipoprotein-spermine com- 
plex was found only in the sera of patients with 
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cancer or chronic infection [4]. Confirmation of 
these results was provided by the finding that 
naturally occurring antibodies to polyamines exist 
in human sera [5] and rabbit sera [6,7]. 
To determine the level of bound polyamines in 
sera, Quash et al. [8] developed methods for link- 
ing antipolyamine antibodies linked via their car- 
bohydrate residues to substituted latex spheres. 
This new approach permitted us to present 
evidence for bound polyamines in human plasma 
and furthermore demonstrated that their amount 
was greater in patients with gastrointestinal 
cancers than that in patients with non-malignant 
gastrointestinal disorders [9]. 
Now it is well established that polyamines can be 
bound enzymically to proteins by the action of 
tissue transglutaminases and factor XIII [lo, 1 I]. 
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When the factor XIII-mediated incorporation of 
putrescine into plasma proteins derived from 44 
patients with bronchopulmonary cancer was com- 
pared to that from 18 patients with sarcoidosis or 
tuberculosis 2 types of kinetic data were obtained. 
Whereas the plasmas from all the patients of the 
control group showed linear kinetics, those from 
only 24 cancer patients showed linear kinetics, the 
others showing kinetics typical of substrate inhibi- 
tion. PAGE analysis of [‘4C]putrescine-bound 
plasma proteins showed around 15 different 
bands. Among them we identified, with the help of 
the corresponding specific antisera, 4 protease in- 
hibitors: ai-antitrypsin, auz-macroglobulin, al-an- 
tichymotrypsin and antithrombin III [ 121. 
2.2. Preparation of antipolyamine antibodies 
covalently bound to magnetic latex 
This finding is not restricted to plasma since 
other authors have also identified numerous 
cellular proteins able to bind polyamines under the 
action of transglutaminase (review [13]). However, 
experimental data which would provide direct 
evidence for plasma proteins already containing 
bound polyamines in vivo are not available. 
Aminopolystyrene magnetic latex spheres of 
0.5-1.5 pm diameter were obtained from Ad- 
vanced Magnetics (USA). Antipolyamine anti- 
bodies were partially purified by ammonium 
sulphate precipitation from a human serum which 
was chosen on the basis of its response in an 
automated nephelometric assay to latex- 
spermidine and latex-spermine [ 151. This reaction 
can be specifically inhibited by 35, 43 or 48% with 
free putrescine, spermidine or spermine, respec- 
tively. This human serum behaves as a 
heterogeneous population of antibodies with dif- 
ferent specificities for tetra-, tri- and diamines as 
demonstrated in [16] for an experimental an- 
tipolyamine antiserum. 
We therefore undertook a study of plasma from 
mice bearing the Lewis lung carcinoma (3LL), in 
order to determine whether protein-bound poly- 
amines can be found in plasma after grafting 
tumour cells to the animal, if they are specific for 
tumour growth or inflammation and whether they 
are formed early or later after tumour graft. 
Coupling of human oxidized antipolyamine im- 
munoglobulins to hydrazine-substituted magnetic 
latex particles was accomplished as described [B]. 
Determination of the protein content [17] before 
and after coupling permitted us to calculate that 
there were 121 pug immunoglobulins linked per mg 
latex. 
The reactivity of antipolyamine-bound latex was 
checked by a visual agglutination test on glass 
slides with spermine linked to poly(L-glutamic 
acid) (PLG) as described in [8]. 
The results of this investigation will be reported 
along with evidence showing that the increase in 
protein-bound polyamines is accompanied by a 
concomitant decrease in the putrescine-binding 
capacity of plasma proteins in mice grafted with 
the Lewis carcinoma. 
2.3. Immunopurification of protein-bound 
polyamines 
2. MATERIALS AND METHODS 
2.1. Mice 
(i) 3 mg latex-antipolyamine were incubated 
with 10~1 mouse plasma diluted in 300~1 GBL 
buffer [O.l M glycine, 50 mM borate, pH 8.5, 
0.14 M NaCl, 0.1% Synperonic PE/L62 (ICIS.A., 
Clamart, France)]. After gentle shaking for 2 h at 
37°C the latex-antipolyamine was washed 7 times 
in GBL buffer. The absence of protein in washings 
was verified using the Coomassie blue technique 
1181. 
26 female C57B16 x DBA2 Fi hybrid mice were (ii) To control specificity, latex-antipolyamine 
used for the experiment: 20 were grafted with the was preincubated for 1 h at 37°C with 0.7 mM 
Lewis lung carcinoma, 3 non-grafted mice were in- spermine as insulin-spermine prepared as described 
jected with heat-inactivated Brucella abortus and 3 for PLG-spermine [19], then added to other ali- 
untreated mice served as controls [14]. Plasma quots of the same plasma examined in (i) above. 
samples were collected using sodium citrate After washings, the magnetic latex spheres were 
(0.129 M), dialyzed with 2 changes against 10 mM heated in a boiling water bath for 5 min with 
Tris (pH 7.5), 0.14 M NaCl (in order to eliminate 50 mM Tris-HCl, pH 6.8, 1% SDS, 1% p- 
free polyamines), distributed into aliquots of 50 ~1 mercaptoethanol (&ME) to release any proteins 
and stored at -70°C. with bound polyamines. After magnetization, 
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supernatants were put onto slots in the slab gel, 
prepared according to conditions described in [20]. 
Gels were stained with silver nitrate [21]. 
2.4. Putrescine-binding capacity of plasma 
proteins by action of exogenous 
transglutaminase 
Transglutaminase was purified from guinea pig 
liver [22]. 1 unit corresponds to the amount of en- 
zyme capable of inserting 2.1 nmol putrescine into 
114pg methylcasein in the presence of 67 PM 
putrescine over 1 h at 37°C. 
To experimental tubes containing 30 ~1 dialysed 
plasma diluted to 1% in Tris buffer (10 mM Tris- 
HCl, pH 7.5, 0.14 M NaCl) were added [‘“Cl- 
putrescine (125 nCi) in amounts ranging from 90 
to 540pM. 20~1 transglutaminase (0.2 U) was 
added to the mixture. The reaction was initiated by 
the addition of calcium (8 mM) in the presence of 
DTT (8 mM). The volume was adjusted to 95 ~1 
with the Tris buffer. The control contained all 
reagents except plasma proteins which were re- 
placed by buffer. After incubation for 2 h at 37°C 
with gentle shaking, 30 ~1 incubation mixture were 
spotted onto a Whatmann 3MM filter paper disk 
presoaked with 100~1 of 100 mM EDTA and 
treated as in [ 121. Protein determination on plasma 
was according to Lowry et al. [ 171. 
3. RESULTS 
3.1. Control of the immunolatex 
3.1.1. PAGE analysis of proteins dissociated from 
immunolatex not incubated with plasma 
Densitometer tracings of the protein bands 
separated after treatment of immunolatex by PME 
show 3 proteins of 70, 53 and 22 kDa (fig.2A). 
These protein bands correspond to heavy chains H 
b and y) and light chains L of immunoglobulins 
immobilized on latex. 
3.1.2. Reactivity 
As shown in fig. 1, 500 pug immunolatex were ag- 
glutinated in the presence of 230 nmol spermine 
bound to PLG (PLG-spermine) but no aggregation 
was observed in the presence of PLG only. 
3.2. PAGE analysis of proteins dissociated from 
immunolatex incubated with normal mouse 
plasma 
As shown in fig.2B, antipolyamine antibody- 
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Fig. 1. Agglutination on a glass slide of latex antipoly- 
amine suspended at 3.3 mg latex/ml in 50 mM Tris- 
citrate, pH 8.1, 0.14 M NaCl, 0.1% Tween 20 with buf- 
fer alone (l), with spermine (0.2pmol) bound to PLG 
(300,~g) (2) or with non-substituted PLG (3). 
bound latex spheres isolated 3 proteins from nor- 
mal mouse plasma. In addition to the 3 protein 
bands corresponding to thep, y and light chains of 
covalently bound antipolyamine antibodies, there 
exist 2 proteins of 82 and 27 kDa which are well 
separated and a third which comigrates with the 
Hy chains at approx. 55 kDa. 
3.3. PAGE analysis of proteins dissociated from 
immunolatex incubated with plasma from 
tumour-bearing mice 
In mice bearing the Lewis tumour, at the third 
week after graft, in addition to the three proteins 
isolated from normal mouse plasma, at least 8 
other proteins of higher molecular mass (5 of 94, 
110, 130, 145 and 160 kDa, and 3 of > 170 kDa) 
had also bound polyamines (fig.2D). 
Before continuing, the specificity of antipoly- 
amine latex spheres and the contribution of the in- 
flammatory process to the protein profile on 
PAGE had to be established. 
3.3.1. Specificity 
Specificity was verified by preincubating anti- 
polyamine latex spheres with 0.7 mM spermine as 
insulin-spermine before adding plasma. As shown 
in fig.2D, preincubation of latex with insulin- 
spermine inhibits the binding of all these proteins 
to the antipolyamine-latex, including those found 
in normal mice plasma, thereby indicating that 
spermine was one of the haptens recognized by 
bound antibodies. 
3.3.2. Inflammation 
The 3LL tumour is known to induce an inflam- 
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Fig.2. Densitometer tracings of proteins isolated by antipolyamine antibodies after incubation with: buffer alone (Al), 
plasmas of normal mice (A2) or mice infected with B. abortus (A3), or mice bearing the Lewis carcinoma 3 weeks after 
the graft (A4, ---: immunolatex preincubated with spermine bound to insulin) or 1 (Bl), 2 (B2), 3 (B3) or 4 (B4) 
weeks after the graft. Separation on 9% (A) or 7.5% (B) polyacrylamide gel. 
matory hepatomegaly and a non-metastatic 
splenomegaly. It was therefore possible that 
protein-bound polyamines were a reflection of the 
inflammatory rather than of the malignant state. 
To investigate this, protein-bound polyamines 
were studied in mice in which liver and spleen 
hypertrophy was induced by intravenous injection 
of B. abortus as in [23]. Fig.2C shows that poly- 
amines are carried by four proteins: 3 which cor- 
respond to those found in normal mice, but with 
amplification of the band at 82 kDa; a fourth of 
65 kDa, absent in normal mice. 
Thus, with the exception of polyamines bound 
on a 65 kDa protein which could be specific for the 
inflammatory process, protein-bound polyamines 
are apparently nog influenced by the inflammatory 
condition accompanying hepato-splenomegaly. 
3.4. Protein-bound polyamines during the growth 
of the Lewis tumour 
With specificity of interaction assured and the 
contribution of the inflammatory process 
evaluated, the question as to whether the binding 
of polyamines to plasma proteins is an early or late 
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Table 1 
August 1987 
Transglutaminase-mediated putrescine-binding capacity of plasma proteins in mice 
Mice K, (mM) V “IaX 
(nmol PUT bound/ 
/g protein) 
Controls 
Lewis tumour 1” 
2 
3 
4 
B. abortus 10 days 
’ No. of week(s) after Lewis tumour grafting 
b Values are means + SD 
’ Significant difference from control group 
0.27 -t O.Olb 1.04 + 0.22 
0.33 +- 0.09 0.72 + 0.15 
0.28 * 0.13 0.46 + 0. lo’ 
0.40 +- 0.17 0.42 k 0.07’ 
0.26 k 0.11 0.45 -t 0.05’ 
0.72 + 0.28 3.73 -t 1.52’ 
The kinetics of the transglutaminase-mediated insertion of putrescine (PUT) into plasma proteins was linear in the 
Lineweaver-Burk plots and so V,,,,, and K, could be determined 
event after tumour graft could be approached. 
A study of protein-bound polyamines in the 
plasma of mice at weeks 1, 2, 3 and 4 after tumour 
graft was undertaken. From the results in fig.3, it 
is apparent that polyamines bound to high-Mr pro- 
teins can be detected from as early as the first week 
after tumour graft. An increase of these protein- 
bound polyamines takes place up to the third week 
and by the fourth week decreases. 
Although these results provide strong evidence 
for the binding of polyamines to high-M, plasma 
proteins during growth of the Lewis tumour in 
mice, they do not give information on the type of 
bond linking the PA to proteins. In this context it 
has been well established that polyamines can be 
bound by a transglutaminase-mediated type of 
reaction [24] to glutamine residues of proteins in y- 
glutamylamine links. Were this the case here, these 
glutamine residues in plasma proteins should be 
less reactive towards exogenous transglutaminase. 
3.5. Polyamine-binding capacity of plasma 
proteins in &mow-grafted mice 
Since the human antibodies used here showed 
extensive cross-reaction with spermine, spermidine 
and putrescine [1,16], we can define them as anti- 
polyamine antibodies. Furthermore, as spermine 
but not putrescine precipitates proteins such as 
fibronectin [25], the accessibility of glutamine 
residues in plasma protein to transglutaminase was 
investigated with putrescine. 
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A Lineweaver-Burk plot was used to express the 
results (11 V = f( 1 /S)). In all cases, the kinetics of 
polyamine binding was linear and permitted the 
V,,,X and apparent K, to be calculated. 
As shown in table 1, when compared to control 
values V,,, decreased progressively as tumour 
growth took place during the first and second 
weeks. In contrast, the I’,,,,, of plasma proteins 
from mice injected with B. abortus was significant- 
ly higher (about 2.5fold) than those in controls. 
These results suggest that the decrease in V,,,,, 
observed in tumour-grafted mice is independent of 
the hypertrophic process accompanying tumour 
growth. It should also be noted that no differences 
in K,,, values could be detected between control and 
3LL-grafted mice, whereas a significant increase in 
K, appeared in mice infected with B. abortus. 
The decrease of I’,,,,, observed in mice bearing 
Lewis lung carcinoma could be related to a 
decrease in the number of transglutaminase- 
sensitive residues in proteins, resulting from in- 
creased insertion of primary amines (polyamines, 
cNH2 protein-bound lysine) on glutamine residues 
in plasma proteins. 
4. DISCUSSION 
Our immunochemical approach associated with 
molecular mass determination on PAGE permitted 
the separation of protein-bound polyamine from 
Volume 220, number 1 FEBS LETTERS August 1987 
the plasma of mice and the unambiguous tein carriers may be altered in secondary structure 
demonstration of an increase in the number of and hence their antigenicity and thus their 
these proteins bearing polyamines during growth capabilities of eliciting an antibody response. 
of the 3LL tumour. These new proteins of high These antibodies could then react with the very 
molecular mass were: (i) not present when im- proteins responsible for their induction, forming 
munolatex was preincubated with 0.7 mM sper- immune complexes and as such their bound poly- 
mine bound to insulin and (ii) independent of any amines would no longer be available for interac- 
concomitant inflammatory and hypertrophic pro- tion with the antipolyamine antibodies bound to 
cess as experimentally induced inflammation with magnetic latex spheres. This is a distinct possibili- 
heat-inactivated B. abortus showed only one band ty, since we have previously presented evidence for 
at 65 kDa in addition to the 3 found in normal the existence of immune complexes containing 
plasma. polyamines in human plasma [9]. 
These polyamines could be bound to cellular 
proteins within the tumour and then released into 
the circulation as demonstrated for fibronectin in 
cellular culture media [26], or could be excreted in 
the free state in plasma and bound to existing 
plasma proteins by the action of factor XIII as we 
have shown previously [12] or that of intrahepatic 
transglutaminase. There is evidence in the 
literature for this latter hypothesis. Indeed, 
Rosenblum et Russell [27] have shown that in rats 
injected with [14C]polyamine, hepatic transglu- 
taminase is responsible for the binding of poly- 
amines to proteins within 5 min following 
injection. Our results do not permit us to choose 
between these two alternatives. 
At this stage of our investigations, it seems clear 
that bound polyamines merit further study in the 
light of the ‘polyamine status’ [28] of individuals 
under conditions of physiological and pathological 
growth. The identification of their protein compo- 
nent is a sine qua non for understanding circu- 
lating polyamine homeostasis. 
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As regards the nature of the polyamine-protein 
bond, y-glutamyl-amine bonds were suspected. 
Their direct measurement would have required 
quantities of mouse plasma substantially greater 
than the 1 ml which was obtained per mouse. We 
therefore tested this hypothesis indirectly by 
measuring the accessibility of any remaining free 
amide groups of glutamine residues in plasma pro- 
teins to purified exogenous tissue transglu- 
taminase. The results (table 1) show clearly that the 
capacity of plasma proteins to bind polyamines 
decreases with t&our growth, independently of 
the inflammatory process. 
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